MSFT 419.78 0.4234% AAPL 225.36 0.5039% NVDA 149.123 2.6594% GOOGL 180.02 -0.183% GOOG 181.75 -0.1209% AMZN 206.566 -0.1325% META 583.0 -0.0292% AVGO 176.035 -1.607% TSLA 339.0599 -3.1257% TSM 191.05 -1.546% LLY 813.99 -2.2164% V 308.82 -0.4866% JPM 239.89 0.2507% UNH 615.58 -1.5466% NVO 105.956 -2.8729% WMT 84.965 0.8966% LVMUY 120.91 -5.0793% XOM 120.78 0.2573% LVMHF 605.0 -5.1263% MA 529.85 -0.0509%

Regeneron Pharmaceuticals Inc

Healthcare US REGN

822.585USD
-3.095(0.37%)

Last update at 2024-11-12T16:52:00Z

Day Range

818.88831.00
LowHigh

52 Week Range

684.80998.33
LowHigh

Fundamentals

  • Previous Close 825.68
  • Market Cap107228.60M
  • Volume188391
  • P/E Ratio29.07
  • Dividend Yield-%
  • EBITDA4424.50M
  • Revenue TTM13100.10M
  • Revenue Per Share TTM122.57
  • Gross Profit TTM 7020.00M
  • Diluted EPS TTM33.48

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 4858.80M 9325.80M 3810.40M 2429.10M 2553.50M
Minority interest - - - - -
Net income 4338.40M 8075.30M 3513.20M 2115.80M 2444.40M
Selling general administrative 2115.90M 1824.90M 1346.00M 1834.80M 1556.20M
Selling and marketing expenses - - - - -
Gross profit 10612.50M 13634.20M 7377.20M 7081.20M 6276.70M
Reconciled depreciation 341.40M 286.20M 235.90M 210.30M 148.20M
Ebit 4738.90M 8946.80M 3576.60M 1999.50M 2386.20M
Ebitda 5173.30M 9383.10M 3867.30M 2209.80M 2534.40M
Depreciation and amortization 434.40M 436.30M 290.70M 210.30M 148.20M
Non operating income net other 179.30M 436.30M 290.70M 249.50M 47.30M
Operating income 4738.90M 8946.80M 3576.60M 2209.80M 2534.40M
Other operating expenses 7178.90M 7124.90M 4920.50M 5653.60M 4176.40M
Interest expense 59.40M 57.30M 56.90M 30.20M 28.20M
Tax provision 520.40M 1250.50M 297.20M 313.30M 109.10M
Interest income 160.10M - - 88.10M 13.70M
Net interest income 100.70M -57.30000M -56.90000M -30.20000M -28.20000M
Extraordinary items - - - - 68.00M
Non recurring 255.10M - - - -
Other items - - - - -
Income tax expense 520.40M 1250.50M 297.20M 313.30M 109.10M
Total revenue 12172.90M 16071.70M 8497.10M 7863.40M 6710.80M
Total operating expenses 5618.50M 4687.40M 3800.60M 4871.40M 3742.30M
Cost of revenue 1560.40M 2437.50M 1119.90M 782.20M 434.10M
Total other income expense net 119.90M 379.00M 233.80M 219.30M 19.10M
Discontinued operations - - - - -
Net income from continuing ops 4338.40M 8075.30M 3513.20M 2115.80M 2444.40M
Net income applicable to common shares 4338.40M 8075.30M 3513.20M 2115.80M 2444.40M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 33080.20M 29214.50M 25434.80M 17163.30M 14805.20M
Intangible assets 1038.60M 915.50M - - -
Earning assets - - - - -
Other current assets 386.60M 933.00M 332.40M 1164.00M 959.30M
Total liab 7107.10M 6550.50M 6666.00M 6138.00M 3715.50M
Total stockholder equity 25973.10M 22664.00M 18768.80M 11025.30M 11089.70M